Healthium Medtech, a global medtech company with a growing portfolio across surgical, post-surgical, advanced wound care, arthroscopy and infection prevention, announced that it has agreed to acquire a controlling stake in Paramount Surgimed Ltd., one of India’s largest manufacturers and exporters of surgical blades, scalpels and dermal biopsy products.

Healthium Medtech是一家全球医疗技术公司，其在手术、术后、高级伤口护理、关节镜和感染预防领域的业务组合不断增长。该公司宣布已同意收购印度最大的手术刀片、手术刀和皮肤活检产品制造商和出口商之一Paramount Surgimed Ltd.的控股权。

The non-surgical business of Paramount, including its lifestyle and hygiene business will be carved out prior to the transaction and retained with the Grover family..

派拉蒙的非手术业务，包括其生活方式和卫生业务，将在交易之前被剥离并保留在格罗弗家族中。

With this move, Healthium will expand its specialised presence in the surgical consumables segment, where Paramount’s blades and dermal biopsy categories represent a logical extension of its existing business line. This alignment creates a two-way synergy, allowing Healthium to broaden the range of solutions it offers while enabling both organisations to serve their respective customer bases with a more comprehensive product line.

通过此举，Healthium将扩大其在手术耗材领域的专业影响力，而Paramount的刀片和皮肤活检类别是对其现有业务线的合理延伸。这种协同效应创造了双向共赢，使Healthium能够拓宽其提供的解决方案范围，同时让两家公司都能通过更全面的产品线服务于各自的客户群体。

Paramount’s scaled manufacturing platform, coupled with its high-quality portfolio, offers a unique value proposition to customers globally. When combined with Healthium’s scale and market reach, this acquisition is expected to unlock opportunities for accelerated commercial expansion, shared R&D and development of differentiated, high-quality innovations..

派拉蒙公司规模化的制造平台，加上其高质量的产品组合，为全球客户提供了独特的价值主张。结合Healthium的规模和市场覆盖范围，此次收购有望释放加速商业扩张、共享研发以及开发差异化、高质量创新的机会。

Paramount brings over three decades of specialised manufacturing expertise and has a global footprint built largely through exports, which account for more than 95% of its revenue. The company serves more than 300 OEM and branded customers across 100+ countries, supported by a complete suite of international product registrations, including EU MDR & USFDA.

派拉蒙拥有三十多年的专业制造经验，其全球业务主要通过出口建立，出口收入占其总收入的95%以上。该公司为100多个国家的300多家原始设备制造商和品牌客户提供服务，拥有完整的一套国际产品注册认证，包括欧盟医疗器械法规（EU MDR）和美国食品药品监督管理局（USFDA）认证。

Paramount manufactures over 250 million devices annually making it one of the largest players in its space..

派拉蒙每年生产超过 2.5 亿台设备，成为该领域最大的制造商之一。

Anish Bafna, CEO & MD of Healthium Medtech, emphasised that the acquisition enhances Healthium’s global surgical consumables business and complements its strategy of delivering high-precision technology to healthcare professionals worldwide. “Paramount has earned the trust of clinicians across markets through consistent performance, rigorous execution and strong manufacturing excellence.

Healthium Medtech首席执行官兼董事总经理阿尼什·巴夫纳强调，此次收购增强了Healthium的全球外科耗材业务，并与其向全球医疗专业人员提供高精度技术的战略相辅相成。 “Paramount通过持续的性能表现、严谨的执行力和强大的制造优势，赢得了各市场临床医生的信任。

As Paramount joins the Healthium family, our focus will be on ensuring a smooth integration that preserves what customers value, while also boosting service and supply reliability. We see this as an opportunity to align our collective strengths toward a more competitive global position in surgical consumables,” he said..

“随着百特加入 Healthium 大家庭，我们的重点将是确保顺利整合，在保留客户所重视的内容的同时，提升服务和供应的可靠性。我们认为这是将我们的集体优势对齐，朝着在手术耗材领域更具全球竞争力地位迈进的机会，”他说道。

Shaily Grover, Managing Director of Paramount Surgimed Ltd., expressed confidence in the partnership and its future trajectory. “We are delighted to partner with Healthium, a leading player in the medtech space, for our surgical disposables business. Their operational expertise and established global reach makes them an ideal partner for our next phase of growth.

帕拉蒙特 Surgimed 有限公司董事总经理 Shaily Grover 对此次合作及其未来的发展轨迹充满信心。“我们很高兴与医疗科技领域的领先企业 Healthium 合作，共同发展我们的外科一次性用品业务。他们在运营方面的专业知识和已建立的全球影响力使他们成为我们下一阶段增长的理想合作伙伴。

Paramount has always stood for precision, quality and trust and we are confident the brand will grow significantly with Healthium. As we join forces, we will use the broader resources of a larger platform and an expanded portfolio to improve reliability and expand access across the markets we serve,” he said..

“ Paramount 一直代表着精确、质量和信任，我们相信该品牌将随着 Healthium 获得显著增长。在我们携手合作之际，我们将利用更广阔的大平台资源和更广泛的产品组合来提高可靠性，并扩大我们在所服务市场中的覆盖范围，”他说道。

Daksh Grover, Director of Paramount Surgimed Ltd., envisions this partnership to be highly synergistic. As the company enters this new partnership, he remains committed to leading Paramount and delivering sustained high growth,

达克什·格罗弗，派拉蒙 Surgimed 有限公司的董事，认为这一合作关系将具有高度的协同效应。随着公司进入这一新的合作伙伴关系，他仍然致力于领导派拉蒙并实现持续的高增长。

ensuring continuity for customers while unlocking new opportunities across global markets. “This partnership paves the way for an unprecedented scale of impact. With our combined product portfolio and global capabilities, we believe we are well positioned to redefine the global surgical consumables landscape and move with a speed and scale never seen before,” he said..

确保客户业务的连续性，同时在全球市场中释放新的机遇。 “这一合作为前所未有的影响力规模铺平了道路。凭借我们组合的产品组合和全球能力，我们相信我们有能力重新定义全球外科耗材领域的格局，并以前所未有的速度和规模前进，”他说道。

This acquisition underscores Healthium’s commitment to strengthening India’s medtech manufacturing ecosystem, expanding access to globally benchmarked products and driving innovation-led growth across the surgical care continuum.

此次收购凸显了Healthium致力于加强印度的医疗技术制造生态系统，扩大获得全球标杆产品的渠道，并推动整个外科护理领域的创新引领增长。